BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 21917312)

  • 1. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L
    Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
    Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between soluble Fas ligand levels and complications after allogeneic bone marrow transplantation].
    Huang X; Wan J; Guo N; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):83-5. PubMed ID: 11877055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease.
    Kanda Y; Tanaka Y; Shirakawa K; Yatomi T; Nakamura N; Kami M; Saito T; Izutsu K; Asai T; Yuji K; Ogawa S; Honda H; Mitani K; Chiba S; Yazaki Y; Hirai H
    Bone Marrow Transplant; 1998 Oct; 22(8):751-4. PubMed ID: 9827971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in the expression of Fas/Fas-ligand and the lymphocyte subset reconstitution according to the occurrence of acute GVHD.
    Lee S; Chong SY; Lee JW; Kim SC; Min YH; Hahn JS; Ko YW
    Bone Marrow Transplant; 1997 Nov; 20(10):883-8. PubMed ID: 9404931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The correlated research of acute graft versus host disease after allogeneic stem cell transplantation].
    Yang F; Chen H; Liu GX; Lu M; Feng K; Zhang YG; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):264-8. PubMed ID: 16875562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ; Lin MF; Cai Z
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation.
    Rank A; Nieuwland R; Toth B; Pihusch V; Delker R; Hiller E; Kolb HJ; Pihusch R
    Transplantation; 2011 Jul; 92(2):244-50. PubMed ID: 21629178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].
    Chen YH; Huang XJ; Guo NL; Ren HY; Zhang YC; Xu LP; Gao ZY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):61-3. PubMed ID: 12697096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
    Pihusch V; Rank A; Steber R; Pihusch M; Pihusch R; Toth B; Hiller E; Kolb HJ
    Transplantation; 2006 May; 81(10):1405-9. PubMed ID: 16732177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.